Acquisition News Lifted Silk Road Medical (SILK) in Q2
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter 2024 investor letter.
Silk Road Medical Inc (SILK)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Slotnik Capital Charles Slotnik | 0 | $0 | 0% | |
| 2. | Glazer Capital Paul Glazer | 0 | $0 | 0% | |
| 3. | PDT Partners Peter Muller | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | ||
| 5. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.99 | 11,700 | 17,807 | 2024-03-05 | Filing | ||
| $41.30 | 2,500 | 132,179 | 2021-11-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $27.10 | 2,268 | 162,926 | 2024-08-19 | Filing | ||
| $27.00 | 66 | 289,707 | 2024-07-03 | Filing | ||
| $17.17 | 9,877 | 500,925 | 2024-03-05 | Filing | ||
| $17.17 | 3,800 | 205,711 | 2024-03-05 | Filing | ||
| $17.17 | 5,481 | 287,773 | 2024-03-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,049,161 | $49,683,205 | 0.27% | |
| 2. | 3,012,320 | $36,961,167 | 0% | |
| 3. | 2,966,730 | $36,401,777 | 0% | |
| 4. | 2,891,769 | $35,482,005 | 0% | |
| 5. | 2,010,983 | $24,674,761 | 0% |
News See All
Silk Road Medical (SILK) Surged After the Acquisition News
Wasatch Global Investors, an asset management company, released its “Wasatch Micro-Cap Growth-U.S. Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Here’s Why Silk Road Medical (SILK) was up 47.8% in Q2
Baron Funds, an investment management company, released its “Baron Discovery Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Silk Road Medical, Inc (NASDAQ:SILK) Q1 2024 Earnings Call Transcript
Silk Road Medical, Inc beats earnings expectations. Reported EPS is $-0.36, expectations were $-0.4.
Silk Road Medical, Inc (NASDAQ:SILK) Q4 2023 Earnings Call Transcript
Silk Road Medical, Inc beats earnings expectations. Reported EPS is $-0.33, expectations were $-0.4.
Here’s Why Silk Road Medical (SILK) Came Under Pressure Despite 37% Growth
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Small Cap Growth Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here.
Here’s Why Silk Road Medical (SILK) Detracted in Q3
Wasatch Global Investors, an investment management firm, released its “Wasatch Small Cap Growth Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here.
15 Best Falling Stocks To Buy Now
In this piece, we will take a look at the 15 best falling stocks to buy now.
Silk Road Medical, Inc (NASDAQ:SILK) Q3 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Silk Road Medical Third Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode.
Here’s Why Silk Road Medical (SILK) Detracted in Q3
Baron Funds, an investment management company, released its “Baron Discovery Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here.